WM · DEEP VALUE BRIEFING

Waste Management, Inc. (WM)

published May 7, 2026 · price now $204.63 · market cap $82.7B

WATCH · medium confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

EXECUTIVE SUMMARY

  • Verdict: WATCH
  • The Business: Waste Management (WM) is a quintessential "wonderful business." Its virtually irreplaceable landfill network, route density, and regulatory barriers create an exceptional, recession-resistant moat.
  • The Valuation: At $221 (32x P/E) against intrinsic value estimates of $155–$165, WM is priced for absolute perfection. A 10.4% ROIC, while respectable, does not mathematically justify this premium.
  • The Risk: The primary risk is not permanent capital loss from business failure, but severe opportunity cost and multiple compression. Buying an asset-heavy business with zero margin of safety frequently results in a decade of "dead money" returns.

SUMMARIZED KEY ARGUMENTS

  • The Aggressive (Risky) Stance: WM is scarce environmental infrastructure, not just a trash hauler. With FCF growing at 30.4% and an aggressive push into renewable natural gas (RNG) and healthcare waste (Stericycle), investors should pay a premium. Strict adherence to textbook valuation models leads to missing out on elite compounders.
  • The Conservative (Safe) Stance: Business quality does not neutralize price risk. A 32x multiple leaves no room for integration missteps or capex inefficiencies. With Net Income down 1.4% YoY, paying a massive premium for a 10.4% ROIC business destroys the margin of safety and sets up the investor for poor forward returns.
  • The Balanced (Neutral) Stance: The moat is undeniable, but it is fully priced. However, stubbornly waiting for a $155 entry may permanently sideline the investor. The solution is conditional accumulation—initiating positions during market dislocations or temporary integration-related sell-offs, rather than chasing at $221 or waiting indefinitely.

RATIONALE (BUFFETT FRAMEWORK) Through the lens of Warren Buffett’s value investing principles, WM presents a classic clash between Business Quality and Margin of Safety.

  • Quality over Volatility & Financial Strength: WM passes Buffett’s quality filters with flying colors. It is essential, understandable, and highly profitable (27.1% ROE, 40.4% Gross Margin). The predictable cash flows generated by local network monopolies significantly reduce intrinsic business risk.
  • Margin of Safety: The first rule of value investing is "don't lose money." You protect capital by buying below intrinsic value. WM's current price requires flawless execution of the Stericycle integration and high returns on RNG capex just to justify the present multiple. At $221, there is no margin of safety.
  • Permanent vs. Temporary (Valuation Risk): The market is treating WM as an ultra-safe haven. If market sentiment shifts, or if the market decides a mature industrial business should trade at its historical mean of ~20x earnings, investors at $221 will suffer severe multiple compression. Even if the business continues to grow revenues at double digits, the stock could stagnate for years.

REFINING THE INVESTOR'S PLAN Original Plan: Wait indefinitely for a broader market dislocation to bring the share price back toward the $155–$165 intrinsic value range, while monitoring Stericycle integration, CapEx, and volume/pricing balance.

Refined Plan: We agree with the original premise: WM is a phenomenal enterprise priced for absolute perfection. However, as the Neutral Analyst astutely noted, anchoring rigidly to a $155 value might result in missing out on a generational compounder entirely.

  1. Shift from "Wait Indefinitely" to "Staged Conditional Accumulation": Do not chase the stock at $221, but do not demand $155 to start. Set alerts for the $190–$200 range (a reasonable premium to intrinsic value given the moat) or wait for a confirmed breakdown of the $220 support level to test lower bounds.
  2. Monitor the Stericycle Integration for "Good Crises": Healthcare waste brings compliance complexity and liability exposure. If integration stumbles early, the market may overreact, creating a temporary earnings dip. As value investors, we look to exploit exactly these types of temporary setbacks to acquire permanent moats.
  3. Track the True Return on CapEx: Validate that the heavy investments in recycling automation and RNG are producing high returns on incremental capital, rather than just inflating the asset base while Net Income lags.

LEARNING FROM PAST MISTAKES The Trap of Overpaying for Defensive Quality: The most painful trap for a value investor is capitulating on valuation just to get a "safe" stock into the portfolio. It is easy to fall in love with a durable moat and predictable cash flow, but we cannot confuse a great company with a great stock. When we have made this mistake in the past, we ended up holding great companies that delivered terrible investment returns because the premium valuation slowly bled out over time. Patience is the ultimate weapon; price matters immensely.

FINAL STANCE: WATCH

The model

Every input behind the value range, so you can check the work or change an assumption and redo it yourself. Computed deterministically from SEC filings (fiscal 2025), updated Oct 4, 2026; the market price was $204.63. Values are estimates, not predictions.

Owner earnings (Buffett)

Discounts owner earnings: the cash the business generates for its owners after the spending needed to keep it running.

Value per share: $63.84 / $91.19 / $91.19 (conservative / base / optimistic)

Starting Owner Earnings$2.9B
Growth: conservative / base / optimistic (2015–2025)7.9% / 7.9% / 7.9%
Projection10 years
Discount rate8.6%
Terminal growth2.5%
Shares outstanding402M
The history the growth rates come from (15 years)
2011$1.4B
2012$1.2B
2013$867M
2014$1.8B
2015$1.6B
2016$1.7B
2017$1.8B
2018$1.9B
2019$1.8B
2020$1.9B
2021$2.2B
2022$1.8B
2023$1.9B
2024$2.2B
2025$3.0B

Free cash flow

Discounts reported free cash flow: operating cash flow minus capital expenditure.

Value per share: $86.37 / $159.80 / $327.30 (conservative / base / optimistic)

Starting Free Cash Flow$3.4B
Growth: conservative / base / optimistic (2020–2025)-1.3% / 9.5% / 25.3%
Projection10 years
Discount rate9.4%
Terminal growth4.5%
Shares outstanding402M
The history the growth rates come from (15 years)
2011$1.1B
2012$756M
2013$1.1B
2014$1.1B
2015$1.2B
2016$1.6B
2017$1.5B
2018$1.8B
2019$2.0B
2020$1.7B
2021$2.2B
2022$1.6B
2023$1.7B
2024$2.0B
2025$2.6B

Two-stage FCFF (Damodaran)

Projects revenue, operating margin and reinvestment, then discounts free cash flow to the firm at the weighted cost of capital.

Value per share: $41.58 / $54.15 / $66.17 (conservative / base / optimistic)

Starting Damodaran FCFF$3.3B
Growth: conservative / base / optimistic (2011–2025)2.3% / 4.6% / 6.8%
Projection10 years
Risk-free rate5.28%
Equity risk premium4.15%
Beta1.00
Cost of equity9.43%
After-tax cost of debt5.97%
Equity weight80%
WACC (discount rate)8.73%
Target operating margin (base)16.9%
High-growth stage5 years
Terminal growth2.5%
Shares outstanding404M

This briefing is from May 7, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

生成最新简报 →Watch the video briefingGet the iPhone app

周一价值信

每周一封:杰出价值投资者买了什么、卖了什么,以及我们的看法。

请每周给我发送一封 DeepValues 周一价值信。我可以随时退订。仅供参考,不构成投资建议。 隐私政策